Vaccino anti-morbillo-parotite-rosolia e allergia all'uovo Finalmente una svolta epocale

Translated title of the contribution: Measles-mumps-rubella vaccine and egg allergy: An epochal turning-point

Irene Berti, Giorgio Longo

Research output: Contribution to journalArticle

Abstract

Since measles and mumps components used in measles-mumps-rubella (MMR) vaccine are grown in cultures of fibroblast from chick embryos, the safety of administering MMR vaccine to patients allergic to eggs has been debated for long time. Finally international recommendations and Italian guide line clearly state that MMR vaccine do not contain significant amounts of egg cross-reacting proteins and so there are no risks for patients allergic to eggs. Furthermore, children with egg allergy are at low risk of allergic reaction to MMR, even if they have a history of severe anaphylaxis to egg ingestion: they can be vaccinated regularly, without previous skin test with the vaccine and the procedure does not need to be done in a hospital.

Translated title of the contributionMeasles-mumps-rubella vaccine and egg allergy: An epochal turning-point
Original languageItalian
Pages (from-to)36-40
Number of pages5
JournalMedico e Bambino
Volume29
Issue number1
Publication statusPublished - Jan 2010

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Measles-mumps-rubella vaccine and egg allergy: An epochal turning-point'. Together they form a unique fingerprint.

  • Cite this